Low-Dose Tamoxifen Plus Intermittent Fasting Shifts Breast Cancer Risk Biomarkers in 110 High-Risk Women
In a 6-month, four-arm randomized phase II trial of 110 high-risk women (mean age 52, BMI 25), low-dose tamoxifen (10 mg every other day) significantly raised…